static distension of the shoulder joint. Reeves (1966) used serial distension of the shoulder as treatment in only 2 patients and these took three months to recover fully. There were no data on the duration of the disease in either paper and there were no controls, so it is possible that the improvement seen might be due to the natural history of the disease.
We are currently conducting a controlled study of hydrostatic distension in the treatment of adhesive capsulitis in my department and hope to be able to give a definitive answer in due course. In the meantime, I have to reiterate that the value of this treatment is not proved. Yours faithfully FE BRUCKNER Lack of understanding of two fundamental mechanisms in AlP hampers the development of a single, universally-effective treatment for the acute attack. Firstly, the mechanism by which the 'porphyrinogenic' substances initiate the acute attack of AlP is not fully elucidated. They are thought to induce aminolaevulinic acid synthetase (ALA-S) activity, predominantly in the liver where the majority of the excess production of aminolaevulinic acid (ALA) and porphobilinogen (PBG) occurs (McColl et al. 1981) . None of the currently advocated treatments is universally effective in reducing ALA-S activity.
The second difficulty is that the mechanism by which the abdominal, psychiatric and neurological symptoms are mediated remains unexplained. ALA and PBG have been implicated as neurotoxins, though, as was pointed out by Yeung Laiwah et al., infusion of these substances does not cause the typical symptoms of the acute attack: The fact that there are hormonal systems common to gut and nervous tissue has obviously hot been missed in Glasgow. The discussion paper alludes to attempts to influence one such system, the endorphin/opiate receptor system.
In Sweden, standard treatment of the acute attack of AlP remains the administration of large quantities of carbohydrate, although some limited experience with infusions of haematin has been gained (Lithner 1982) . Most patients with an established acute attack vomit copiously and cannot retain the large volumes of Hycal or glucose solutions that they are required to take. All the patients admitted to the Central Hospital in Boden in an acute attack had been vomiting for at least 24 hours before allowing themselves to be admitted. Thus most patients must be administered their carbohydrate in the form of glucose infusions.
The hyponatraemia that may occur in the acute attack of AlP is, at least in part, caused by the inappropriate secretion of antidiuretic hormone (Hellman et al. 1962) . The hypovolaemia that also occurs demands fluid replacement with saline and thus the infusion of large volumes of glucose solutions with little or no electrolyte content may be dangerous. The ability of the infused glucose to increase hepatocellular glucose uptake may also be questioned. Transient glucose intolerance may be seen (Waxman et al. 1967 ) and appears to be due to increased insulin resistance at receptor level that will reduce glucose uptake by the hepatocyte.
Assuming the effect of glucose to be mediated by the suppression of ALA-S activity, a direct release of glucose within the cell may be more effective, thereby allowing it to penetrate the mitochondrion more rapidly in order to exert its effect on the enzyme. To this end, together with Dr K Oberg of the University of Uppsala, I have tried treating patients with acute attacks of AlP with glucagon (Forrest & Oberg 1982) . This hormone was administered both intravenously and subcutaneously to 3 patients during five mild to moderate attacks of AlP. The dose was adjusted to maintain hyperglycaemia at or above 7 mrnol/l, which was achieved in. four of the five attacks. During the fifth attack the patient remained normoglycaemic. All attacks settled within 3-7 days, comparable to the time taken for similar attacks in these same patients to settle when treated by glucose infusions.
It was appreciated that hepatic stores of glycogen might well be depleted by the time the glucagon treatment was started, so the patients in the last three attacks were also given up to two litres of 5% glucose per 24 hours intravenously. It was the first of these patients that failed to become hyperglycaemic on glucagon.
In order to test the hypothesis that gut hormones may be involved in mediating the symptoms of the acute attack of AlP, we took blood samples four-hourly during the first 24-48 hours after admission in two patients in two AlP attacks. Levels of gastrin, insulin, pancreatic . polypeptide (PP), somatostatin and vasoactive intestinal peptide were found to be normal, although insulin and PP levels increased to four times basal levels at times when the patients complained of increased abdominal pain. It is, however, impossible to ascertain whether these increases are related to the cause of the exacerbation or simply reflect a response to stress. Perhaps measurement of substance P or neurotensin might yield more interesting results.
The results of treatment with glucagon are highly preliminary. No severe attacks were treated, but the idea remains attractive especially if the glucagon can be given early in the attack while glycogen stores in the liver may still be plentiful. If other workers can show that glucagon, by causing glycogenolysis within the hepatocyte, reduces ALA-S activity -even if in only a proportion of acute attacks -then a case could be made for supplying sufferers with the drug to administer to themselves by subcutaneous or intramuscular injection as early as possible in the acute attack in order to abort it. RICHARD Sir, We write to report a case of accidental substance P injection into a human subject which we believe illustrates one or two points of importance and interest.
Substance P is a small peptide (I I amino acids) discovered by von Euler and thought to be the neurotransmitter in primary sensory nerves (Lembeck 1953) . It is present in large quantities in the gut and central nervous system. Animal experiments have shown it to be a powerful vasodilator agent and it induces hypotension in various species when injected intravenously (Dobbins et al. 1982 , von Euler 1981 . We report here the effects of an accidental injection of substance P into a human subject.
The victim of the accident was a female student aged 23, weighing 45 kg. Whilst performing an
